May 22, 2020 / 10:35 PM / 7 days ago

Peer-reviewed data shows Gilead's drug effective against COVID-19 -NIH

May 22 (Reuters) - The National Institutes of Health (NIH) said on Friday peer-reviewed data published in the New England Journal of Medicine from a trial testing Gilead Sciences Inc's remdesivir showed the drug was superior to the standard of care for COVID-19.

Last month, the NIH announced early data from the study, which began in February with 1,063 participants in 10 countries.(bit.ly/2Tvd6I1) (Reporting by Manojna Maddipatla in Bengaluru; Editing by Aditya Soni)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below